Home Healthcare Pharmaceuticals Fungal Keratitis Treatment Market

Fungal Keratitis Treatment Market Size, Share & Trends Analysis Report By Keratitis Type (Noninfectious Keratitis, Infectious Keratitis), By Drug Class (Polyenes, Azoles, Fluorinated Pyrimidines), By Route of Administration (Oral, Injections, Topical Antifungals), By Age Group (0-18 Years, 18-39 Years, 40-64 Years, 65 Years), By Distribution Channel (Hospitals, Drug stores, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR1605DR | Pages: 158
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Fungal Keratitis Treatment Market, By Keratitis Type 2022-2034 (USD MILLION/ Units)
    1. Noninfectious Keratitis
    2. Infectious Keratitis
      1. Bacterial Keratitis
      2. Fungal Keratitis
      3. Viral Keratitis
      4. Acanthamoeba Keratitis
  2. Fungal Keratitis Treatment Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Polyenes
      1. Natamycin
      2. Amphotericin B
    2. Azoles
      1. Voriconazole
      2. Ketoconazole
      3. Miconazole
      4. Fluconazole
      5. Itraconazole
    3. Fluorinated Pyrimidines
      1. Flucytosine
      2. Others
  3. Fungal Keratitis Treatment Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Injections
    3. Topical Antifungals
  4. Fungal Keratitis Treatment Market, By Age Group 2022-2034 (USD MILLION/ Units)
    1. 0-18 Years
    2. 18-39 Years
    3. 40-64 Years
    4. 65 Years
  5. Fungal Keratitis Treatment Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Drug stores
    3. Others
  6. Regional Fungal Keratitis Treatment Market
    1. North America
      1. North America Fungal Keratitis Treatment Market By Keratitis Type 2022-2034 (USD MILLION/ Units)
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
      2. North America Fungal Keratitis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Polyenes
          1. Natamycin
          2. Amphotericin B
        2. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        3. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
      3. North America Fungal Keratitis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injections
        3. Topical Antifungals
      4. North America Fungal Keratitis Treatment Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. 0-18 Years
        2. 18-39 Years
        3. 40-64 Years
        4. 65 Years
      5. North America Fungal Keratitis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Drug stores
        3. Others
      6. U.S.
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      7. Canada
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
    2. Europe
      1. Europe Fungal Keratitis Treatment Market By Keratitis Type 2022-2034 (USD MILLION/ Units)
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
      2. Europe Fungal Keratitis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Polyenes
          1. Natamycin
          2. Amphotericin B
        2. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        3. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
      3. Europe Fungal Keratitis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injections
        3. Topical Antifungals
      4. Europe Fungal Keratitis Treatment Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. 0-18 Years
        2. 18-39 Years
        3. 40-64 Years
        4. 65 Years
      5. Europe Fungal Keratitis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Drug stores
        3. Others
      6. U.K.
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      7. Germany
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      8. France
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      9. Spain
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      10. Italy
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      11. Russia
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      12. Nordic
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      13. Benelux
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      14. Rest of Europe
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
    3. APAC
      1. APAC Fungal Keratitis Treatment Market By Keratitis Type 2022-2034 (USD MILLION/ Units)
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
      2. APAC Fungal Keratitis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Polyenes
          1. Natamycin
          2. Amphotericin B
        2. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        3. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
      3. APAC Fungal Keratitis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injections
        3. Topical Antifungals
      4. APAC Fungal Keratitis Treatment Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. 0-18 Years
        2. 18-39 Years
        3. 40-64 Years
        4. 65 Years
      5. APAC Fungal Keratitis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Drug stores
        3. Others
      6. China
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      7. Korea
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      8. Japan
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      9. India
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      10. Australia
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      11. Taiwan
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      12. South East Asia
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      13. Rest of Asia-Pacific
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
    4. Middle East and Africa
      1. Middle East and Africa Fungal Keratitis Treatment Market By Keratitis Type 2022-2034 (USD MILLION/ Units)
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
      2. Middle East and Africa Fungal Keratitis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Polyenes
          1. Natamycin
          2. Amphotericin B
        2. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        3. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
      3. Middle East and Africa Fungal Keratitis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injections
        3. Topical Antifungals
      4. Middle East and Africa Fungal Keratitis Treatment Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. 0-18 Years
        2. 18-39 Years
        3. 40-64 Years
        4. 65 Years
      5. Middle East and Africa Fungal Keratitis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Drug stores
        3. Others
      6. UAE
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      7. Turkey
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      8. Saudi Arabia
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      9. South Africa
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      10. Egypt
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      11. Nigeria
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      12. Rest of MEA
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
    5. LATAM
      1. LATAM Fungal Keratitis Treatment Market By Keratitis Type 2022-2034 (USD MILLION/ Units)
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
      2. LATAM Fungal Keratitis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Polyenes
          1. Natamycin
          2. Amphotericin B
        2. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        3. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
      3. LATAM Fungal Keratitis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injections
        3. Topical Antifungals
      4. LATAM Fungal Keratitis Treatment Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. 0-18 Years
        2. 18-39 Years
        3. 40-64 Years
        4. 65 Years
      5. LATAM Fungal Keratitis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Drug stores
        3. Others
      6. Brazil
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      7. Mexico
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      8. Argentina
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      9. Chile
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      10. Colombia
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
      11. Rest of LATAM
        1. Noninfectious Keratitis
        2. Infectious Keratitis
          1. Bacterial Keratitis
          2. Fungal Keratitis
          3. Viral Keratitis
          4. Acanthamoeba Keratitis
        3. Polyenes
          1. Natamycin
          2. Amphotericin B
        4. Azoles
          1. Voriconazole
          2. Ketoconazole
          3. Miconazole
          4. Fluconazole
          5. Itraconazole
        5. Fluorinated Pyrimidines
          1. Flucytosine
          2. Others
        6. Oral
        7. Injections
        8. Topical Antifungals
        9. 0-18 Years
        10. 18-39 Years
        11. 40-64 Years
        12. 65 Years
        13. Hospitals
        14. Drug stores
        15. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.